Inhibitory effect of BMP-2 on the proliferation of breast cancer cells

Related Experiment Video

Updated: May 21, 2026

Covalent Binding of BMP-2 on Surfaces Using a Self-assembled Monolayer Approach
10:23

Covalent Binding of BMP-2 on Surfaces Using a Self-assembled Monolayer Approach

Published on: August 26, 2013

Anan Chen1, Dingding Wang, Xueting Liu

  • 1Institute of Bioengineering, College of Life Science and Technology, Jinan University, Guangzhou, Guangdong 510632, PR China.

Molecular Medicine Reports
|June 28, 2012
PubMed

Insights

Bone morphogenetic protein-2 (BMP-2) inhibits breast cancer cell proliferation and promotes apoptosis. BMP-2 also reduced tumor growth in vivo, suggesting its potential as an early-stage breast cancer inhibitor.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Bone morphogenetic proteins (BMPs) regulate crucial cellular functions like proliferation, differentiation, and apoptosis.
  • Aberrant cell proliferation is a hallmark of cancer, necessitating the identification of novel therapeutic targets.

Purpose of the Study:

  • To investigate the effect of BMP-2 on the proliferation and apoptosis of human breast cancer cell lines (MDA-MB-231 and MCF-7).
  • To explore the potential of BMP-2 as an inhibitor for early-stage breast cancer.

Main Methods:

  • MTT assay to assess cell proliferation.
  • Flow cytometry to analyze cell cycle arrest and apoptosis.
  • Western blot analysis to detect key protein expression (p21 and cleaved caspase-3).
  • Xenograft tumor models in nude mice to evaluate in vivo efficacy.

Main Results:

  • BMP-2 significantly inhibited the proliferation of MDA-MB-231 and MCF-7 breast cancer cells.
  • BMP-2 induced G1 cell cycle arrest and promoted apoptosis in these cells.
  • Increased expression of p21 and cleaved caspase-3 was observed, correlating with proliferation suppression.
  • BMP-2 treatment reduced xenograft tumor formation in vivo.

Conclusions:

  • BMP-2 exhibits anti-proliferative and pro-apoptotic effects on breast cancer cells.
  • The observed effects are potentially mediated by the upregulation of p21 and cleaved caspase-3.
  • BMP-2 demonstrates therapeutic potential as an inhibitor of early-stage breast cancer.

More Related Videos

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells11:06

Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells

Published on: May 20, 2015

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...